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ABSTRACT 
Optical spectroscopy and imaging methods have proved to have potential to discriminate between normal and abnormal 
tissue types through minimally invasive procedures. Raman spectroscopy and Optical Coherence Tomography (OCT) 
provides chemical and morphological information of tissues respectively, which are complementary to each other. When 
used individually they might not be able to obtain high enough sensitivity and specificity that is clinically relevant. In 
this study we combined Raman spectroscopy information with information obtained from OCT to enhance the sensitivity 
and specificity in discriminating between Colonic Adenocarcinoma from Normal Colon. OCT being an imaging 
technique, the information from this technique is conventionally analyzed qualitatively. To combine with Raman 
spectroscopy information, it was essential to quantify the morphological information obtained from OCT. Texture 
analysis was used to extract information from OCT images, which in-turn was combined with the information obtained 
from Raman spectroscopy. The sensitivity and specificity of the classifier was estimated using leave one out cross 
validation (LOOCV) method where support vector machine (SVM) was used for binary classification of the tissues. The 
sensitivity obtained using Raman spectroscopy and OCT individually was 89% and 78% respectively and the specificity 
was 77% and 74% respectively. Combining the information derived using the two techniques increased both sensitivity 
and specificity to 94% demonstrating that combining complementary optical information enhances diagnostic accuracy. 
These results demonstrate that a multimodal approach using Raman-OCT would be able to enhance the diagnostic 
accuracy for identifying normal and cancerous tissue types. 
1. INTRODUCTION  
It has been demonstrated by previous studies that the combination of Raman spectroscopy and optical coherence 
tomography (OCT) can be used as an effective multimodal tool for disease diagnosis [1-3]. There are two main 
challenges facing the implementation of a combined Raman-OCT system; the implementation of the hardware and the 
analysis of the complementary information obtained from both modalities. As previous studies have focused primarily on 
the implementation of the complex hardware, this study address the issue of combining the information gained from 
these complementary modalities. To be more specific, in this study the biochemical information of tissues from Raman 
spectroscopy and the morphological information of tissues from OCT are quantitatively combined. Further to this the 
accuracy of the classifier using both individual and multimodal information has been assessed and a clear increase in 
classifier accuracy has been detected when the multimodal information was included. These studies demonstrate the 
potential of developing multimodal systems by combining Raman spectroscopy and OCT, which in the future may be 
capable of performing efficient non-invasive optical biopsies. 
In cancer biology neoplasia is the term used for tissues masses which grow independent and faster than the normal 
tissues[4]. A neoplasm, or tumour, can be further classified on the basis of its potential to harm the host as either benign 
or malignant (cancer). According to the Cancer Research UK statistics, there are more than 200 types of cancer. The 
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statistics also show that in the UK in 2010, the number of people diagnosed with cancer reached 325,000 with almost 
157,000 deaths. These figures show that due to the significant number of new cases of cancer being diagnosed and the 
high rates of patient mortality recorded that there exists a continuing demand for intensive research to focus on 
understanding the origins of cancer and to provide a solution for early detection to increase the survival rate.  
Neoplastic cells and tissues are identified and characterised by increases in nuclear material, cell mitoic activity and 
metabolic activity as well as a progressive loss of cell maturation. Studies have shown that specific changes in nucleic 
acid, protein, carbohydrate and lipid content which are associated with neoplastic cells can be characterised using Raman 
spectroscopy.[4] The most common cancer diagnosed in the UK is breast cancer, early research in this field using Raman 
spectroscopy by Frank et al. showed a decrease in spectral intensity associated with the diagnostic peaks corresponding 
to both the lipids and carotenoids for benign breast tissues[5]. Another area of high intensity research has been in the 
area of brain tumours, where normal tissue and neoplastic tumour samples of human origin were extensively studied[6]. 
Preliminary studies on colorectal carcinoma by Feld et al.  have shown intense vibrational modes associated with nucleic 
acids in relation to carcinoma samples[7]. Research in the field of cervical cancer[8], bladder cancer[7], colon cancer[7, 
9], prostate cancer[9] has also been performed and diagnostic bands have been successfully identified in relation to the 
biochemical makeup of these tumours.[10, 11] However, improving the sensitivity (true positive rate) and specificity 
(true negative rate) of cancer detection, still remains to be a challenge while using Raman spectroscopy mainly due to the 
interference of the fluorescence background which is obtained from the sample itself.  
Colorectal neoplasm is an epidemiological disease and is considered the second most common cancer in the UK[12] and 
the fourth most common cancer in the US [13]. The investigation of patients with suspected colorectal cancer, or the 
surveillance of individuals at high risk of the development of colorectal cancer, is currently performed by an endoscopic 
assessment of the colorectal mucosa using colonoscopy. This requires visual assessment of the mucosa, with a targeted 
biopsy of any abnormal areas. Both the colonoscopic assessments, and the subsequent histopathological assessment of 
the biopsies, are both highly subjective. The development of novel methodologies that enhance the ability to assess the 
colorectal mucosa would not only improve the targeting of biopsies to the most appropriate areas, but would also 
potentially obviate the need for tissue biopsy. 
The biochemical features associated with both normal and neoplastic tissues can be distinguished due to differences in 
their on-going biological processes[14]. Raman spectroscopy has shown potential to detect subtle biochemical changes 
of various disease states within the body. However, as these changes cause alterations of biomarker concentrations at 
particularly low levels then a very sensitive and powerful technique is required for their detection. Clinical studies on 
colon cancer and pre-cancerous tissues using fluorescence spectroscopy have shown that the spectra obtained from 
malignant and benign abnormalities are very similar in some patients and hence hard to classify [15]. Near-IR Raman 
spectroscopy studies on cancerous colon tissue demonstrated the efficiency of Raman spectroscopy to identify between 
neoplastic and normal tissues[16, 17]. Although previous studies have demonstrated high sensitivities and specificities 
when discriminating between normal and adenocarcinoma colonic tissues, the Raman spectra obtained in these studies 
do not show a significantly different fingerprint spectrum in respect to both normal and abnormal tissue. Another crucial 
factor to be considered would be the occurrence of inter-patient variability in the chemical composition of colonic 
tissues[18]. Therefore, when considering inter-patient variability [14], the classification efficiency may be lower than the 
acceptable limits for using Raman spectroscopy alone as a reliable tool for disease diagnosis.  
The solution to this issue would be to combine Raman spectroscopy with other optical modalities, which can provide 
complementary information for the tissues. Optical coherence tomography (OCT) is a powerful, non-invasive optical 
imaging technique that is capable of providing cross-sectional images of tissues[19, 20]. It is possible to obtain 
morphological information from the tissues with a resolution ~10 µm using OCT. While visual inspection of OCT 
images may be used to assess tissue morphologies, it has been demonstrated that various image-processing approaches 
can extract features from OCT images, which may be used to predict the biochemical state of tissues. An example of 
such processing techniques would be texture analysis of OCT images, which has been successful in discriminating 
between normal and abnormal tissue types[21, 22]. The following investigation demonstrates combining quantitatively 
the information from Raman spectroscopy and OCT to enhance the accuracy of detection [23]. 
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2. MULTI-MODAL ANALYSIS OF TISSUE SAMPLES USING RAMAN SPECTROSCOPY 
AND OCT 
2.1 The Raman spectroscopy system 
The Raman spectroscopic system used in this study was equipped with a diode laser with wavelength 785 nm (Sacher 
Lasertechnik) for Raman excitation. For detection, the system was equipped with a monochromator with a 400 lines/mm 
grating, blazed at 850 nm and a deep depletion, back illuminated and thermoelectrically cooled CCD camera (Andor 
technologies). The laser was focused through a 40x objective (Nikon, NA 0.65) onto the sample in such a way that the 
power at the sample plane was 50 mW which is below the power density that can create any disruption to the 
morphology or chemical composition of the tissue [24]. With a 500 µm, confocal aperture, the confocal cylinder of the 
system had a base diameter of 12.5 µm and a height of 10 µm. Tissue samples were placed on a quartz coverslip before 
being loaded on to the confocal Raman microscope. The back-reflection of the excitation beam was used to ensure that 
the confocal volume was within the sample and the position of the sample volume from the quartz coverslip was same 
for all the samples. The Raman spectrum from each sample was acquired with an acquisition time of 5 s. 
2.2 Optical coherence tomography 
The OCT images were acquired utilizing a home-built Fourier domain optical coherence tomography (FDOCT) 
system[25]. The technique adopted in FDOCT permits the acquirement of a cross-sectional image of the sample of 
interest avoiding scanning of the reference arm through the depth range [26, 27], The back-reflected or back-scattered 
signal from the sample is acquired in a single event and the Fourier transform of the collected spectrum delivers the 
depth information of the sample. 
The FDOCT system used in this study consisted of a fiber-coupled superluminescent diode (SLED371-HP1, Superlum 
Diodes, Russia) as the short-coherence light source with a bandwidth of 50 nm cantered at 840 nm. Light was split 
between the reference arm and the sample arm by a 3-dB fiber coupler (FC850-40-50-APC, Thorlabs, NJ, USA). The 
reference arm was composed by a high-reflectivity gold-protected mirror (PF10-03-M01, Thorlabs, NJ, USA). Light on 
the sample arm was focused on the tissue of interest by a telecentric microscope objective with a working distance of 25 
mm (LSM03-BB, Thorlabs, NJ, USA); scanning along the sample was accomplished by a sliver-coated galvanometric 
mirror (GVS001, Thorlabs, NJ, USA). Back-scattered light from the sample recombine with the reference light at the 3-
dB fiber coupler and the interference signal was detected by a custom spectrometer formed by a dispersive optical 
element (volume phase holographic grating, 1200 l/mm, 830 nm, Wasatch Photonics, USA) and a line CCD detector 
(Aviiva EM1, part number EV71YEM1GE2014-BA9, 2048 pixels, pixel size 14×28 μm, e2v, UK). Custom software 
developed using NI Labwindows (National Instruments, TX, USA) was used to control and synchronise the OCT image 
acquisition. All fibres used in the system were single mode for the operation wavelength (SM800-5.6-125, Thorlabs, NJ, 
USA). Using a high-reflectivity mirror (PF10-03-M01, Thorlabs, NJ, USA) as sample and a neutral density filter 
(ND40B, Thorlabs, NJ, USA) along the sample arm, the signal-to-noise ratio (SNR) of the system has been measured to 
be about 97 dB with a CCD integration time of 80 μs. The SNR could be improved by increasing the integration time 
[25]. 
The FDOCT system had an axial resolution of around 6.2 μm limited to the light source properties and a lateral 
resolution of about 17 μm due to the spot size on sample. The full depth range was 1.7 mm in air, when considering a 
typical colon refractive index of 1.4 [28], whilst the maximum depth range decreases to about 1.2 mm. The lateral scan 
range can be set up to 5 mm with the galvanometric mirror with 512 lines acquired. In particular, the field of view of the 
images presented in this work was restricted to 1.1 mm in depth and 3.2 mm in width. The total acquisition time for a full 
image is about 1 second due to the CCD integration time and the data processing. The tissue sample placed on the quartz 
slide was scanned using the OCT system and cross sectional images were acquired from each tissue sample.  
2.3 Tissue samples 
The tissue samples used in this study were obtained from Tayside Tissue Bank (Tissue request no. TR000289). The 
tissue samples were snap-frozen immediately following their dissection and they were stored at -70 0C. Each sample had 
a dimension of approximately 2mm x 2mm x 1mm as shown in Figure 1.  
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Figure 1: Typical example of colon sample used for this study. The tissue sample was thawed and placed on a quartz 
coverslip for Raman and OCT measurements 
In this study 33 individual normal and 18 individual tumour samples were used along with 11 samples that were both 
normal and tumour samples (the 11 mixed samples shall hence forth be known as ‘’mix’’) were analysed. For optical 
interrogation, the tissue sample was thawed for 5 minutes and placed on a quartz coverslip (22 mm x 22 mm, thickness 
180 µm) (SPi supplies). OCT image and Raman spectrum were acquired from each sample. Further to image and 
spectral acquisition, the sample was fixed in formalin for histological evaluation. 
 
 
Figure 2: Representative histological images from the tissue samples used [23]. 
2.4 Raman spectra analysis 
All the Raman spectra acquired from the tissue were smoothed with a Savitzky – Golay filter with smooth width 9 and 
degree 3 followed by baseline correction using iterative modified polynomial fitting[29]. The Raman bands that showed 
significant differences were estimated using a student t-test with a significance level of 10-3. A comparison of the Raman 
spectra obtained from two types of tissue samples are shown in Figure 3. 
2.5 Texture analysis on OCT data 
When combining a spectroscopic technique which is usually analysed quantitatively with an imaging technique that is 
usually analysed qualitatively, it is essential to implement a quantification algorithm for the imaging technique. It has 
been demonstrated in previous studies that texture analysis may be an efficient method to quantify OCT images [21, 22]. 
Texture is a measure of the variation of the intensity of a surface and can be quantified using properties such as 
smoothness, coarseness and regularity. The three principle approaches used to describe texture are statistical, structural 
and spectral. Statistical techniques characterise texture by the statistical properties of the grey levels of the points 
comprising a surface. Typically, these properties are computed from the grey level histogram or grey level co‐occurrence 
matrix (GLCM) of the surface. The 16 texture parameters calculated from each image were the “contrast”, “correlation”, 
“energy” and “homogeneity” in four directions (00, 450, 900 and 1350). The algorithm used for evaluating the texture 
parameters and avoiding the non-tissue regions of the image has been detailed in a previous study. [21]  This algorithm 
allowed the calculation of the texture parameters independently of the morphology of the tissue surface.  
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Figure 3: Comparison of Raman signature between normal and tumour tissues. The solid lines shows mean spectra of each 
category and the dotted lines shows the standard deviation. The vertical bar shows Raman bands that shows 
significance difference in student’s T test with significance level p<10-3 [23]. 
 
2.6 Data treatment and discrimination of tissue types 
PCA was used for feature selection and reduction of parameters obtained for both Raman and OCT data. A supervised 
discrimination algorithm using a support vector machine (SVM) with a “linear” kernel was used to perform 
discrimination between the two tissue types. The sensitivity and specificity of each training dataset was evaluated using 
leave one out cross validation (LOOCV). For the Raman and OCT dataset, the first 5 PCs were chosen to build the 
classifier. In the multimodal approach, the first 5 PCs of data from each modality were combined to build the classifier. 
3. RESULTS AND DISCUSSIONS 
When Raman spectroscopy data alone was considered, the sensitivity and specificity obtained was 89% and 77% 
respectively. It was also observed that visual examination alone for the OCT images would be too subjective in order to 
make a reliable diagnosis. This is also evident from the sensitivity and specificity obtained from the texture analysis of 
OCT data which were 78% and 74% respectively. When multi-modal information was considered, where Raman 
spectroscopy and OCT information were combined, 94% sensitivity and 94% specificity were obtained respectively [23]. 
Figure 4 shows the cluserplot of PC1 of Raman data vs. PC1 of OCT data along with the support vectors for the 
combined data. 
 
Figure 4: PC1 of Raman data vs. PC1 of OCT data clusterplot showing support vectors for the combined dataset [23]. 
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Previous studies have shown that both Raman spectroscopy and OCT are powerful techniques capable of detecting 
cancers and pre-cancers [15, 21]. However it is essential to assess the accuracy of these techniques so that they may be 
used as a reliable tool for clinical diagnostics. In that context, it is very important to consider inter-patient variability in 
regard to both spectral and morphological information[18]. Although previous studies demonstrated very high sensitivity 
and specificity in tissue discrimination [17], our observations revealed that inter-patient variability may reduce these 
numbers when implemented for practical applications. This is where multi-modal approaches that provide 
complementary information become relevant. Combination of OCT and Raman has been proposed as a potential multi-
modal tool for disease diagnosis [1, 2].  
4. CONCLUSION 
When combining Raman spectroscopy and OCT, there are two major challenges. One is combining the hardware and the 
other is combining the information acquired from both of these modalities. This study attempted to address the method 
by which information from both modalities could be combined. The main challenge to this study was the consideration 
that the representations of the information from these two modalities are significantly different. Raman spectra need to 
be quantified to obtain useful inferences, while conventionally the OCT images are visually analysed. The approach 
taken in this study to combine these two modalities was to quantify the OCT images using texture analysis. The texture 
information obtained from OCT could be readily combined with the spectral information from Raman spectroscopy. The 
sensitivity and specificity of the classifier saw a greater than 10% increase when multi-modal information was used for 
tissue discrimination as opposed to using single modality. This shows the potential of combining Raman spectroscopy 
and OCT for implementing reliable, optical diagnostic systems. While colon tissue samples were used in this study, it 
would be possible to extend such approaches for discriminating other tissue types as well. 
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